Literature DB >> 36263106

Prognostic and Therapeutic Implications of Renal Insufficiency in Heart Failure.

Se Yong Jang1,2,3, Dong Heon Yang1,2,3.   

Abstract

The heart and kidneys are closely related vital organs that significantly affect each other. Cardiorenal syndrome is the term depicting the various spectra of cardiorenal interaction mediated by the hemodynamic, neurohormonal, and biochemical cross-talk between these two organs. In patients with heart failure (HF), both the baseline and worsening renal function are closely related to prognosis. However, for both investigational and clinical purposes, the unified definition and classification of renal injury are still necessary. Renal insufficiency is caused by multiple factors, and categorizing them into monogenous subgroups of phenotype is difficult. Various clinical scenarios related to the chronicity of HF, progression of renal dysfunction, and issues related to pharmacologic therapies associated with the prognosis of patients with HF have been reviewed in this study.
Copyright © 2022. Korean Society of Heart Failure.

Entities:  

Keywords:  Heart failure; Prognosis; Renal insufficiency

Year:  2022        PMID: 36263106      PMCID: PMC9383346          DOI: 10.36628/ijhf.2021.0039

Source DB:  PubMed          Journal:  Int J Heart Fail        ISSN: 2636-154X


  79 in total

1.  Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure.

Authors:  Harini Chittineni; Nobuyuki Miyawaki; Sailaja Gulipelli; Steven Fishbane
Journal:  Am J Nephrol       Date:  2007-01-24       Impact factor: 3.754

2.  Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction.

Authors:  Wendy McCallum; Hocine Tighiouart; Elaine Ku; Deeb Salem; Mark J Sarnak
Journal:  Kidney Int       Date:  2019-06-11       Impact factor: 10.612

Review 3.  Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Authors:  Min-Seok Kim; Ju-Hee Lee; Eung Ju Kim; Dae-Gyun Park; Sung-Ji Park; Jin Joo Park; Mi-Seung Shin; Byung Su Yoo; Jong-Chan Youn; Sang Eun Lee; Sang Hyun Ihm; Se Yong Jang; Sang-Ho Jo; Jae Yeong Cho; Hyun-Jai Cho; Seonghoon Choi; Jin-Oh Choi; Seong Woo Han; Kyung Kuk Hwang; Eun Seok Jeon; Myeong-Chan Cho; Shung Chull Chae; Dong-Ju Choi
Journal:  Korean Circ J       Date:  2017-09-18       Impact factor: 3.243

4.  Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Francis D Pagani; Susan L Myers; Lynne W Stevenson; Michael M Givertz; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-10-08       Impact factor: 10.247

5.  Prognostic Value of Cystatin C-Derived Estimated Glomerular Filtration Rate in Patients with Acute Heart Failure.

Authors:  Se Yong Jang; Dong Heon Yang; Hyeon Jeong Kim; Bo Eun Park; Yoon Jung Park; Hong Nyun Kim; Nam Kyun Kim; Myung Hwan Bae; Jang Hoon Lee; Hun Sik Park; Yongkeun Cho; Shung Chull Chae
Journal:  Cardiorenal Med       Date:  2020-04-21       Impact factor: 2.041

6.  Spironolactone for heart failure with preserved ejection fraction.

Authors:  Bertram Pitt; Marc A Pfeffer; Susan F Assmann; Robin Boineau; Inder S Anand; Brian Claggett; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Brian Harty; John F Heitner; Christopher T Kenwood; Eldrin F Lewis; Eileen O'Meara; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Song Yang; Sonja M McKinlay
Journal:  N Engl J Med       Date:  2014-04-10       Impact factor: 91.245

7.  Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure.

Authors:  H M Krumholz; Y T Chen; V Vaccarino; Y Wang; M J Radford; W D Bradford; R I Horwitz
Journal:  Am J Cardiol       Date:  2000-05-01       Impact factor: 2.778

8.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

9.  Cardiorenal interactions: insights from the ESCAPE trial.

Authors:  Anju Nohria; Vic Hasselblad; Amanda Stebbins; Daniel F Pauly; Gregg C Fonarow; Monica Shah; Clyde W Yancy; Robert M Califf; Lynne W Stevenson; James A Hill
Journal:  J Am Coll Cardiol       Date:  2008-04-01       Impact factor: 24.094

Review 10.  Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine.

Authors: 
Journal:  Med Chir Rev       Date:  1836-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.